NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

SRF Delivers Strong 4QFY26 Performance

Motilal Oswal's latest research report highlights the strong performance of SRF in the fourth quarter of fiscal year 2026. The company's earnings before interest and taxes (EBIT) grew by a substantial 14% year-over-year, driven by significant increases in the EBIT of its key business segments. Specifically, the company's Chemicals business saw a 5% year-over-year jump, while the Performance Films and Foil (PFF) business experienced a 47% year-over-year growth. The Technical Textiles Business (TTB) was also a standout performer, with a 63% year-over-year increase in EBIT.

Despite facing challenges in the specialty chemicals segment due to the global environment, SRF was able to successfully redirect its business away from the Middle East without incurring any loss of volumes. This strategic move has likely contributed to the company's strong performance in the quarter.

Outlook and Recommendations

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Motilal Oswal is optimistic about SRF's future prospects, projecting a compound annual growth rate (CAGR) of 15% for revenue, 21% for earnings before interest, taxes, depreciation, and amortization (EBITDA), and 24% for adjusted profit after tax (Adj. PAT) over the fiscal years 2026-2028. Based on this analysis, the research firm reiterates its BUY rating for the stock and values it on a sum-of-the-parts (SoTP) basis to arrive at a target price of INR3,400.

Business Segment4QFY26 EBIT Growth (YoY)
Chemicals5%
Performance Films and Foil (PFF)47%
Technical Textiles Business (TTB)63%

Investor Takeaway

Investors should consider buying SRF stock due to its healthy performance and positive outlook.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.